Trial Outcomes & Findings for Assessment of Safety of Air Travel in Patients With Birt-Hogg-Dube Syndrome (NCT NCT03040115)
NCT ID: NCT03040115
Last Updated: 2024-01-31
Results Overview
The investigators will measure the number of pneumothoraces that occur either during air travel, or within 24 hours of air travel among patients with Birt-Hogg-Dube syndrome. The incidence of air travel related pneumothorax will be calculated by dividing the number of pneumothoraces to the total number of flights undertaken by the entire cohort.
COMPLETED
104 participants
During air travel or within 24 hours following air travel
2024-01-31
Participant Flow
Participant milestones
| Measure |
Patients Self-reporting With BHD
Patients self-reporting with BHD
|
|---|---|
|
Overall Study
STARTED
|
104
|
|
Overall Study
COMPLETED
|
104
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Patients Self-reporting With BHD
n=104 Participants
Patients self-reporting with BHD
|
|---|---|
|
Age, Continuous
|
50 years
n=104 Participants
|
|
Sex: Female, Male
Female
|
86 Participants
n=104 Participants
|
|
Sex: Female, Male
Male
|
18 Participants
n=104 Participants
|
|
Region of Enrollment
United States
|
104 Participants
n=104 Participants
|
|
Number of Participants with a History of Air Travel
|
99 participants
n=104 Participants
|
PRIMARY outcome
Timeframe: During air travel or within 24 hours following air travelThe investigators will measure the number of pneumothoraces that occur either during air travel, or within 24 hours of air travel among patients with Birt-Hogg-Dube syndrome. The incidence of air travel related pneumothorax will be calculated by dividing the number of pneumothoraces to the total number of flights undertaken by the entire cohort.
Outcome measures
| Measure |
BHD Patients With Air Travel Related Pneumothorax
n=104 Participants
Air travel related pneumothorax in patients with BHD
|
|---|---|
|
Number of Patients With Birt-Hogg-Dube Syndrome Who Experienced Spontaneous Pneumothorax During or Within 24 Hours Following Air Travel
|
8 Participants
|
SECONDARY outcome
Timeframe: 3 yearsThe investigators will catalogue the number of spontaneous pneumothoraces experienced by patients with Birt-Hogg-Dube syndrome.
Outcome measures
| Measure |
BHD Patients With Air Travel Related Pneumothorax
n=104 Participants
Air travel related pneumothorax in patients with BHD
|
|---|---|
|
Number of Patients With Birt-Hogg-Dube Syndrome Who Experience a Spontaneous Pneumothorax
|
79 Participants
|
SECONDARY outcome
Timeframe: 3 yearsThe investigators will measure the incidence of ipsilateral pneumothorax following pleurodesis in order to determine the efficacy (as measured by the rate of pneumothorax recurrence following pleurodesis).
Outcome measures
| Measure |
BHD Patients With Air Travel Related Pneumothorax
n=79 Participants
Air travel related pneumothorax in patients with BHD
|
|---|---|
|
Number of Patients With Birt-Hogg-Dube Syndrome Who Experience Recurrent Pneumothorax Following Pleurodesis
|
29 Participants
|
Adverse Events
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Elizabeth Kopras, Senior Research Associate
University of Cincinnati
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place